Gara Jalqabaatti › Kansara Metastatikii › Missouri › Kansas City
Qorannoo klinikaalii Kansara Metastatikii Kansas City, MO keessatti
Qorannoo 15 Kansara Metastatikii f Kansas City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- St. Lukes Hospital of Kansas City, Kansas City
A Study of ASP3082 in Adults With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- University of Kansas Medical Center, Westwood · Miili 5 fagaatti
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
Namoota walitti qabaa jiraSadarkaa 1
- University of Kansas Hospital-Westwood Cancer Center, Westwood · Miili 5 fagaatti
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Kansas Medical Center, Westwood · Miili 5 fagaatti
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Namoota walitti qabaa jiraSadarkaa 2/3
- Premier Imaging, Kansas City
- St. Joseph Medical Center, Kansas City
- MidAmerica Cancer Care - American Oncology Partners, Kansas City
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
Namoota walitti qabaa jiraSadarkaa 1
- The University of Kansas Medical Center, Westwood · Miili 5 fagaatti
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 3
- HCA Midwest Kansas City, MidAmerica Division, Inc., Kansas City
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Namoota walitti qabaa jiraSadarkaa 3
- Saint Luke's Cancer Institute, Kansas City
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- The University of Kansas Cancer Center - Westwood, Westwood · Miili 5 fagaatti
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Kansas Cancer Center - North, Kansas City
- University of Kansas Hospital-Westwood Cancer Center, Westwood · Miili 5 fagaatti
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Namoota walitti qabaa jiraSadarkaa 3
- University of Kansas Cancer Center - North, Kansas City
- University of Kansas Cancer Center, Westwood · Miili 5 fagaatti
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Namoota walitti qabaa jiraSadarkaa 3
- Saint Luke's Cancer Institute, Kansas City
- The University of Kansas Cancer Center, Westwood · Miili 5 fagaatti
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Namoota walitti qabaa jiraSadarkaa 2/3
- MidAmerica Cancer Care, Kansas City
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Namoota walitti qabaa jiraSadarkaa 3
- University of Kansas Cancer Center, Westwood · Miili 5 fagaatti
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Kansas City
Qorannoo Kansara Metastatikii magaalota biroo keessatti
- Houston, TXQorannoo 104
- New York City, NYQorannoo 93
- Nashville, TNQorannoo 70
- Boston, MAQorannoo 63
- Los Angeles, CAQorannoo 57
- St. Louis, MOQorannoo 54
- Arlington, VAQorannoo 53
- Philadelphia, PAQorannoo 46
- Chicago, ILQorannoo 45
- San Antonio, TXQorannoo 44
- Washington, DCQorannoo 43
- Dallas, TXQorannoo 42
Qorannoo biroo Kansas City keessatti
- Saree OljooQorannoo 34
- Kansara Qara'a Non-Small CellQorannoo 31
- Cufama OnneeQorannoo 25
- Saree (Gosoota Hunda)Qorannoo 21
- Dhibee QaraQorannoo 19
- Kansarii ColorectalQorannoo 16
- Leukemia Myeloidii HamaaQorannoo 15
- Kansarii ProstateQorannoo 14
- Kansarii OvariiQorannoo 11
- ObesityQorannoo 11
- Sukkaraa Gosa 2Qorannoo 11
- Dhibee Onneessaa fi DhiigaQorannoo 11
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.